Bordoli et al., 2014 - Google Patents
A secreted tyrosine kinase acts in the extracellular environmentBordoli et al., 2014
View HTML- Document ID
- 8273596917339734802
- Author
- Bordoli M
- Yum J
- Breitkopf S
- Thon J
- Italiano J
- Xiao J
- Worby C
- Wong S
- Lin G
- Edenius M
- Keller T
- Asara J
- Dixon J
- Yeo C
- Whitman M
- Publication year
- Publication venue
- Cell
External Links
Snippet
Although tyrosine phosphorylation of extracellular proteins has been reported to occur extensively in vivo, no secreted protein tyrosine kinase has been identified. As a result, investigation of the potential role of extracellular tyrosine phosphorylation in physiological …
- 102000004022 Protein-Tyrosine Kinases 0 title abstract description 20
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bordoli et al. | A secreted tyrosine kinase acts in the extracellular environment | |
| Lee et al. | SREBP1c-PARP1 axis tunes anti-senescence activity of adipocytes and ameliorates metabolic imbalance in obesity | |
| DaSilva et al. | Activity-regulated cytoskeleton-associated protein controls AMPAR endocytosis through a direct interaction with clathrin-adaptor protein 2 | |
| Hanamura et al. | Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain | |
| Espigat-Georger et al. | Nuclear alignment in myotubes requires centrosome proteins recruited by nesprin-1 | |
| Thomas et al. | Palmitoylation by DHHC5/8 targets GRIP1 to dendritic endosomes to regulate AMPA-R trafficking | |
| Fabbro et al. | Cdk1/Erk2-and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis | |
| Paroni et al. | PP2A regulates HDAC4 nuclear import | |
| Levaot et al. | Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism | |
| Li et al. | Enzymatic activity of the scaffold protein rapsyn for synapse formation | |
| Navarro‐Lérida et al. | A palmitoylation switch mechanism regulates Rac1 function and membrane organization | |
| Bradley et al. | Integrin signaling through Arg activates p190RhoGAP by promoting its binding to p120RasGAP and recruitment to the membrane | |
| Abu-Thuraia et al. | Axl phosphorylates Elmo scaffold proteins to promote Rac activation and cell invasion | |
| Collin et al. | The Alström syndrome protein, ALMS1, interacts with α-actinin and components of the endosome recycling pathway | |
| Jenkins et al. | Ca2+-dependent facilitation of Cav1. 3 Ca2+ channels by densin and Ca2+/calmodulin-dependent protein kinase II | |
| Vacher et al. | Cdk-mediated phosphorylation of the Kvβ2 auxiliary subunit regulates Kv1 channel axonal targeting | |
| Zhang et al. | The phosphorylation of vinculin on tyrosine residues 100 and 1065, mediated by SRC kinases, affects cell spreading | |
| Chen et al. | Association of connexin43 with E3 ubiquitin ligase TRIM21 reveals a mechanism for gap junction phosphodegron control | |
| Tsujii et al. | Retinoblastoma-binding protein 4-regulated classical nuclear transport is involved in cellular senescence | |
| Yoo et al. | The Mre11-Rad50-Nbs1 complex mediates activation of TopBP1 by ATM | |
| Ackermann et al. | Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly | |
| Williams et al. | Interaction of suppressor of cytokine signalling 3 with cavin-1 links SOCS3 function and cavin-1 stability | |
| Lu et al. | A NudE/14-3-3 pathway coordinates dynein and the kinesin Khc73 to position the mitotic spindle | |
| Sakuma et al. | Novel PKCα-mediated phosphorylation site (s) on cofilin and their potential role in terminating histamine release | |
| Rohrbach et al. | The effector domain of MARCKS is a nuclear localization signal that regulates cellular PIP2 levels and nuclear PIP2 localization |